바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.73 No.5
Citation Share

A Multicenter Study of Pertussis Infection in Adults with Coughing in Korea: PCR-Based Study

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2012, v.73 no.5, pp.266-272
https://doi.org/10.4046/trd.2012.73.5.266
(Hallym University College of Medicine)








(Dankook University Hospital)





(Inha University School of Medicine)



& (2012). A Multicenter Study of Pertussis Infection in Adults with Coughing in Korea: PCR-Based Study. Tuberculosis & Respiratory Diseases, 73(5), 266-272, https://doi.org/10.4046/trd.2012.73.5.266
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: Limited data on the incidence and clinical characteristics of adult pertussis infections are available in Korea. Methods: Thirty-one hospitals and the Korean Centers for Disease Control and Prevention collaborated to investigate the incidence and clinical characteristics of pertussis infections among adults with a bothersome cough in non-outbreak, ordinary outpatient settings. Nasopharyngeal aspirates or nasopharyngeal swabs were collected for polymerase chain reaction (PCR) and culture tests. Results: The study enrolled 934 patients between September 2009 and April 2011. Five patients were diagnosed as confirmed cases, satisfying both clinical and laboratory criteria (five positive PCR and one concurrent positive culture). Among 607 patients with cough duration of at least 2 weeks, 504 satisfied the clinical criteria of the US Centers for Disease Control and Prevention (i.e., probable case). The clinical pertussis cases (i.e., both probable and confirmed cases) had a wide age distribution (45.7±15.5 years) and cough duration (median, 30 days; interquartile range, 18.0~50.0 days). In addition, sputum, rhinorrhea, and myalgia were less common and dyspnea was more common in the clinical cases, compared to the others (p=0.037, p=0.006, p=0.005, and p=0.030, respectively). Conclusion: The positive rate of pertussis infection may be low in non-outbreak, ordinary clinical settings if a PCR-based method is used. However, further prospective, well-designed, multicenter studies are needed.

keywords
Adult, Cough, Incidence, Whooping Cough, Signs and Symptoms

Reference

1.

1. Gonzales R, Sande MA. Uncomplicated acute bronchitis. Ann Intern Med 2000;133:981-91.

2.

2. Hewlett EL, Edwards KM. Clinical practice. Pertussis: not just for kids. N Engl J Med 2005;352:1215-22.

3.

3. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005;24:761-5.

4.

4. de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 2006;53:106-13.

5.

5. Hozbor D, Mooi F, Flores D, Weltman G, Bottero D, Fossati S, et al. Pertussis epidemiology in Argentina: trends over 2004-2007. J Infect 2009;59:225-31.

6.

6. Mayet A, Brossier C, Haus-Cheymol R, Verret C, Meynard JB, Migliani R, et al. Pertussis surveillance within the French armed forces: a new system showing increased incidence among young adults (2007-2009). J Infect 2011;62:322-4.

7.

7. Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002; 185:1448-53.

8.

8. Cherry JD. The science and fiction of the "resurgence" of pertussis. Pediatrics 2003;112:405-6.

9.

9. Tiwari T, Murphy TV, Moran J; National Immunization Program, CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 2005; 54:1-16.

10.

10. Regan J, Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol 1977;6:303-9.

11.

11. Lautrop H. Laboratory diagnosis of whooping-cough or Bordetella infections. Bull World Health Organ 1960; 23:15-35.

12.

12. Glare EM, Paton JC, Premier RR, Lawrence AJ, Nisbet IT. Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. J Clin Microbiol 1990;28:1982-7.

13.

13. Houard S, Hackel C, Herzog A, Bollen A. Specific identification of Bordetella pertussis by the polymerase chain reaction. Res Microbiol 1989;140:477-87.

14.

14. Zouari A, Smaoui H, Kechrid A. The diagnosis of pertussis: which method to choose? Crit Rev Microbiol 2012;38:111-21.

15.

15. Birkebaek NH, Kristiansen M, Seefeldt T, Degn J, Moller A, Heron I, et al. Bordetella pertussis and chronic cough in adults. Clin Infect Dis 1999;29:1239- 42.

16.

16. Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996;173:1256-9.

17.

17. Miller E, Fleming DM, Ashworth LA, Mabbett DA, Vurdien JE, Elliott TS. Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Commun Dis Public Health 2000;3: 132-4.

18.

18. Mink CM, Cherry JD, Christenson P, Lewis K, Pineda E, Shlian D, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992;14: 464-71.

19.

19. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:1672-4.

20.

20. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA 1995;273:1044-6.

21.

21. Loeffelholz MJ, Thompson CJ, Long KS, Gilchrist MJ. Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. J Clin Microbiol 1999;37:2872-6.

22.

22. van Boven M, de Melker HE, Schellekens JF, Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Math Biosci 2000;164:161-82.

23.

23. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24(5 Suppl):S58-61.

24.

24. Korean Centers for Disease Control and Prevention. Sentinal surveillance systems for communicable infectious diseases [Internet]. Cheongwon: Korean Centers for Disease Control and Prevention; [cited 2011 Oct 1]. Available from: http://www.cdc.go.kr.

25.

25. Park WB, Park SW, Kim HB, Kim EC, Oh M, Choe KW. Pertussis in adults with persistent cough in South Korea. Eur J Clin Microbiol Infect Dis 2005;24:156-8.

26.

26. Yaari E, Yafe-Zimerman Y, Schwartz SB, Slater PE, Shvartzman P, Andoren N, et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest 1999;115:1254-8.

27.

27. Strebel P, Nordin J, Edwards K, Hunt J, Besser J, Burns S, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001;183:1353-9.

28.

28. Lee JJ, Yang JH, Hwang IS, Chun BY, Kam S, Lee KS, et al. The BCG, DTaP and IPV vaccination rate and the proportion of vaccination in the public health centers: demonstration project for expansion of national immunization program coverage in Deagu Metropolitan City. J Korean Soc Matern Child Health 2007;11: 33-43.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy